Tamara Ownsworth1,2, Raymond J Chan3,4, Stephanie Jones1, Julia Robertson5, Mark B Pinkham4,6. 1. School of Applied Psychology, Griffith University, Mount Gravatt, Australia. 2. Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia. 3. School of Nursing and Cancer and Palliative Care Outcomes Centre, Queensland University of Technology, Brisbane, Queensland, Australia. 4. Division of Cancer Services, Princess Alexandra Hospital, Metro South Hospital, Woolloongabba, Australia. 5. School of Medicine, Griffith University, South Port, Australia. 6. School of Medicine, University of Queensland, Brisbane, Australia.
Abstract
OBJECTIVE: Telehealth platforms have potential utility for providing remote access to supportive care to people with brain tumour. This systematic review aimed to evaluate the feasibility, acceptability and efficacy of delivering supportive care via telehealth platforms to adults with primary brain tumour and family caregivers. METHODS: A systematic search of PsycINFO, MEDLINE, CINAHL, Embase, Scopus and Cochrane Library was conducted from 1980 to 1st June 2020 to identify eligible studies. Methodological quality was assessed by two independent reviewers. RESULTS: Seventeen articles, reporting on 16 studies, evaluated telephone-based support (5 studies), videoconferencing (3 studies), web-based programs and resources (7 studies) or combined use of videoconferencing and web-based modules (1 study) to deliver supportive care remotely. Caregivers were involved in 31% of interventions. Mean rates of accrual (68%) and adherence (74%) were moderate, whereas acceptability or satisfaction for those completing the interventions was typically high (M satisfied or very satisfied = 81%). Adherence rates were generally higher and clinical gains were more evident for interventions involving real-time interaction as opposed to self-guided interventions. CONCLUSIONS: Telehealth delivery of supportive care is feasible and acceptable to a high proportion of individuals with primary brain tumour and their caregivers. It is recommended that future research focuses on implementation outcomes, including factors influencing the uptake and sustainability of telehealth platforms in practice.
OBJECTIVE: Telehealth platforms have potential utility for providing remote access to supportive care to people with brain tumour. This systematic review aimed to evaluate the feasibility, acceptability and efficacy of delivering supportive care via telehealth platforms to adults with primary brain tumour and family caregivers. METHODS: A systematic search of PsycINFO, MEDLINE, CINAHL, Embase, Scopus and Cochrane Library was conducted from 1980 to 1st June 2020 to identify eligible studies. Methodological quality was assessed by two independent reviewers. RESULTS: Seventeen articles, reporting on 16 studies, evaluated telephone-based support (5 studies), videoconferencing (3 studies), web-based programs and resources (7 studies) or combined use of videoconferencing and web-based modules (1 study) to deliver supportive care remotely. Caregivers were involved in 31% of interventions. Mean rates of accrual (68%) and adherence (74%) were moderate, whereas acceptability or satisfaction for those completing the interventions was typically high (M satisfied or very satisfied = 81%). Adherence rates were generally higher and clinical gains were more evident for interventions involving real-time interaction as opposed to self-guided interventions. CONCLUSIONS: Telehealth delivery of supportive care is feasible and acceptable to a high proportion of individuals with primary brain tumour and their caregivers. It is recommended that future research focuses on implementation outcomes, including factors influencing the uptake and sustainability of telehealth platforms in practice.
Authors: Georgia K B Halkett; Melissa N Berg; Davina Daudu; Haryana M Dhillon; Eng-Siew Koh; Tamara Ownsworth; Elizabeth Lobb; Jane Phillips; Danette Langbecker; Meera Agar; Elizabeth Hovey; Rachael Moorin; Anna K Nowak Journal: J Neurooncol Date: 2022-04-09 Impact factor: 4.506
Authors: Belinda C Goodwin; Fiona Crawford-Williams; Michael Ireland; Sonja March; Suzanne K Chambers; Joanne F Aitken; Jeff Dunn Journal: Eur J Cancer Care (Engl) Date: 2022-04-11 Impact factor: 2.328
Authors: Tamara Ownsworth; Katarzyna Lion; Ursula M Sansom-Daly; Kerryn Pike; Eng-Siew Koh; Georgia K B Halkett; Mark B Pinkham; Raymond J Chan; Haryana M Dhillon Journal: Psychooncology Date: 2022-04-02 Impact factor: 3.955